ORCID as entered in ROS

Select Publications
2023, 'SIRT2 transgenic over-expression does not impact lifespan in mice', Aging Cell, 22, http://dx.doi.org/10.1111/acel.14027
,2022, 'Orphan GPR146: an alternative therapeutic pathway to achieve cholesterol homeostasis?', Trends in Endocrinology and Metabolism, 33, pp. 481 - 492, http://dx.doi.org/10.1016/j.tem.2022.04.008
,2022, 'Metabolic Profiling of Mice with Deletion of the Orphan G Protein-Coupled Receptor, GPR37L1', Cells, 11, http://dx.doi.org/10.3390/cells11111814
,2021, 'Orphan receptor GPR37L1 remains unliganded', Nature Chemical Biology, 17, pp. 383 - 386, http://dx.doi.org/10.1038/s41589-021-00748-z
,2019, 'Regulation of mitochondrial metabolism in murine skeletal muscle by the medium-chain fatty acid receptor Gpr84', FASEB Journal, 33, pp. 12264 - 12276, http://dx.doi.org/10.1096/fj.201900234R
,2019, 'Snail-overexpression induces epithelialmesenchymal transition and metabolic reprogramming in human pancreatic ductal adenocarcinoma and non-tumorigenic ductal cells', Journal of Clinical Medicine, 8, http://dx.doi.org/10.3390/jcm8060822
,2023, 'Misgivings and mispairings in orphan G protein-coupled receptor research: GPR37L1, GPR146 and GPR161 should still be considered orphan receptors', in BRITISH JOURNAL OF PHARMACOLOGY, WILEY, SCOTLAND, Glasgow, pp. 659 - 660, presented at 19th World Congress of Basic and Clinical Pharmacology (WCP), SCOTLAND, Glasgow, 02 July 2023 - 07 July 2023
,2020, Orphan G protein-coupled receptor, GPR37L1: pharmacological toolbox empty once again, http://dx.doi.org/10.1101/2020.09.11.290486
,